# Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

> **NCT00733642** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 15 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **BIOLOGICAL:** PF-04360365 1 mg/kg
- **BIOLOGICAL:** PF-04360365 3 mg/kg
- **BIOLOGICAL:** PF-04360365 5 mg/kg
- **BIOLOGICAL:** PF-04360365 10 mg/kg

## Key facts

- **NCT ID:** NCT00733642
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2009-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733642, "Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00733642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*